We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Technique Restores Fertility to Patients with Fibroids

By HospiMedica International staff writers
Posted on 19 Jun 2017
Researchers have shown that Uterine Fibroid Embolization (UFE) treatments can enable women suffering from uterine fibroids to become pregnant again.

Uterine fibroids often cause infertility and complications during pregnancy, and current standard treatments consist of surgery to remove the fibroids that may cause complications such as hysterectomy, and is not always effective. More...
UFE treatments on the other hand are not yet fully accepted for fertility-preserving treatment in women with symptomatic fibroids.

The researchers from the Department of Interventional Radiology at the Saint Louis Hospital (Lisbon, Portugal) registered the pregnancy rates of 359 women with fertility problems who suffered from uterine fibroids, for a period of nearly six years. All of the women had undergone either partial or conventional UFE treatment. The study was published online in the June 2017 issue of the journal Radiology.

The results of the research showed that 149 women (41.5%) in the study group became pregnant at least once during the 6-year study period. The clinicians used Magnetic Resonance Imaging (MRI) scans and digital subtraction angiography imaging to visualize partial UFE.

Study co-author João Martins Pisco, MD, PhD, from the Department of Interventional Radiology at Saint Louis Hospital in Lisbon, Portugal, said, “Our findings show that UFE is a fertility-restoring procedure in women with uterine fibroids who wish to conceive, and pregnancy following UFE appears to be safe with low morbidity. Women who had been unable to conceive had normal pregnancies after UFE and similar complication rates as the general population in spite of being in a high-risk group. In our study there are now almost 200 newborns following UFE. Our next step will be a randomized study comparing the results of partial and conventional UFE."

Related Links:
Saint Louis Hospital


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Examination & Procedure Light
Vega 80
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.